Income Taxes - Additional Information (Details) $ in Millions	6 Months Ended
Jun. 30, 2026 USD ($)
Income Tax Disclosure [Abstract]
Year-to-date tax liability related to the Jade Biosciences Canada ULC foreign subsidiary.	$ 0.1

Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 740
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 10B
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482685/740-10-50-10B

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(1)(Note 1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

Name:	us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration